Myelodysplastic syndrome patient-derived xenografts: from no options to many

• Christophe Côme,
• Alexander Balhuizen,
• Dominique Bonnet,
• Bo T. Porse

Affiliations

Christophe Côme

The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark

Alexander Balhuizen

The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark

Dominique Bonnet

Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK

Bo T. Porse

The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark